Term
|
Definition
antidote:
LEUCOVORIN--> (folinic acid) to rescue host cells while cancer cells are less affected
|
|
|
Term
|
Definition
|
|
Term
|
Definition
antidotes:
• MESNA--> (2 mercaptoethane sulphonate) conjugates toxic metabolites such as acrolein in the urine and helps to reduce the chemical cystitis.
• DEMECLOCYCLINE--> blocks the effects of ADH
|
|
|
Term
|
Definition
antidote:
AMIFOSTINE--> generates active thiol metabolites, which scavenge free radicals
|
|
|
Term
|
Definition
|
|
Term
|
Definition
antidotes:
DIMETHYL SULFOXIDE--> swabbed onto free radical induced ulcers to stop production
DEXRAZOXANE-->an iron chelator , reduces the cardiomyopathy damage induced by doxorubicin
|
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
antimetabolite ;DOC for AML; MOA :-blocks DNA strand elongation;neurotoxic |
|
|
Term
|
Definition
Oral prodrug, converted to 5-fluorouracil. It inhibits thymidylate synthase. Useful for paclitaxel and doxorubicin - resistant patients with colorectal or metastatic breast cancers |
|
|
Term
|
Definition
alkylating agent - toxic to the CNS-used for CNS cancers |
|
|
Term
|
Definition
Stabilizes the topoisomerase II-DNA complex causing double strand DNA breaks during DNA replication. Dose limiting leukopenia. Treats first time, and metastatic testicular cancer |
|
|
Term
|
Definition
UniqueTopoisomerase 1 inhibitor, preventing religation of bits of helices; causes accumulation of single stranded breaks in DNA. Dose -limiting neutropenia |
|
|
Term
|
Definition
|
|
Term
|
Definition
Nonsteroidal androgen antagonist (NSAA )which inhibits the translocation of steroid receptors to the nucleus . 5-alpha reductase inhibitor-inhibits synthesis of dihydrotestosterone .Both used to treat prostate cancer |
|
|
Term
|
Definition
Nonsteroidal androgen antagonist (NSAA )which inhibits the translocation of steroid receptors to the nucleus . 5-alpha reductase inhibitor-inhibits synthesis of dihydrotestosterone .Both used to treat prostate cancer |
|
|
Term
|
Definition
GnRH analogues which acts as a partial agonists at GnRH receptors. When administered in constant doses to maintain stable blood levels, it inhibit the release of LH and FSH. Used in the treatment of prostate cancer |
|
|
Term
|
Definition
This is an unconjugated chimeric(murine/human)antiCD20 monoclonal antibody which binds to the CD20 antigen on follicular B cells in Non Hodgkins lymphoma |
|
|
Term
|
Definition
Antiestrogen for hormone-sensitive tumors |
|
|
Term
|
Definition
Inhibits bcr-abl tyrosine kinase found in chronic myelocytic leukemia(CML) |
|
|
Term
|
Definition
|
|
Term
|
Definition
Inhibits ribonucleotide reductase ; stops conversion of ribonucleotides to deoxyribonucleotides.;for myeloproliferative disorders |
|
|
Term
what are the two major categories of anticancer drugs? |
|
Definition
CYTOTOXIC DRUGS- effect both cancer and normal cells-->especially dividing cells NEWER DRUGS-target entities in the cancer cells which are absent or different in normal cells |
|
|
Term
how is RESISTANCE developed in cancer cells vs. drugs that first need to be activated before affects are seen? |
|
Definition
resistance is achieved when cancer cell can limit/stop ACTIVATING ENZYME |
|
|
Term
what is DOSE LIMITING TOXICITY? |
|
Definition
Drug toxicity towards a particular organ is so serious that it puts a limit on the dose of that drug that may be used in treatment--> DOXORUBICIN in the heart |
|
|